Pangea Oncology and General University Hospital of Catalonia (Grupo Quironsalud), a hospital with oncology and thoracic surgery sector operating since 2016, has signed an agreement under which the company Will manage the pneumology sector for the next 3 years, Effective May 1, 2023, with annual renewal.
He from Pangea has explained that this contract is part of the Society’s strategy to expand its oncological core in areas of therapeutic synergy, pulmonology and interventional pulmonology in particular, being one of them.
For this Pangea would be included as JChief of the Pneumology Service with Dr. Antonio Torres, PhD, Pulmonologist of recognized international reputation, Professor at the University of Barcelona, Member of the Executive Committee of CIBERES (Cyber of Respiratory Diseases), and has held various medical positions of excellence including Head of the Pneumology Service and the Institute of Pulmonology and Thoracic Surgery and head of the section of the Respiratory Surveillance Unit, all at the Hospital Clínic de Barcelona. Dr. Torres is supported by the scientific community internationally as one of the foremost exponents of COVID19.
Within the convergence area with oncology, the doctor will lead a team of excellence Special focus on Interventional Pneumology techniques, In which he already demonstrates the EBUS technique (Endo Bronchial Ultrasound) with the Society, and in which he includes the cryobiopsy technique for the first time in the private sector in Barcelona.
Pangea Oncology Estimates Pulmonology Division Will generate at least 10% of consolidated revenue In this exercise.